论文部分内容阅读
The solution-phase synthesis of a muramyl dipeptide (MDP) analogue of Nα- [4-chlorocinnamoyl-L-alanyl-D-isoglutaminyl]-L-lysine (MDA, 2) is reported that possesses the features of easy feasibility, safety and low cost in large scale of synthesis.